{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:29:52Z","timestamp":1784723392726,"version":"3.55.0"},"reference-count":67,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Cardiac amyloidosis (CA) results mainly from the infiltration of the myocardium by either immunoglobulin light-chain fibrils (AL) or transthyretin fibrils (ATTR), causing restrictive cardiomyopathy and eventually death if untreated. AL derives from monoclonal immunoglobulin light chains produced by plasma cell clones in the bone marrow, while ATTR is the misfolded form of hepatically derived transthyretin (TTR) protein and can be hereditary (ATTRv) or wild-type (ATTRwt). Over the last decade, improvements in diagnostic imaging and better clinical awareness have unleashed a notable presence of CA in the community, especially ATTR in the elderly population. These multimodality imaging modalities include echocardiography, cardiac magnetic resonance, and radionuclide scintigraphy with bone-avid tracers. There has been remarkable progress in the therapeutic landscape as well, and there are disease-modifying therapies available now that can alter the course of the disease and improve survival if initiated at an early stage of the disease. There remains an unmet need for detecting this disease accurately and early so that these patients can benefit the most from newly emerging therapies.<\/jats:p>","DOI":"10.3390\/jcm13144075","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T08:47:41Z","timestamp":1720774061000},"page":"4075","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnostic Modalities in the Detection of Cardiac Amyloidosis"],"prefix":"10.3390","volume":"13","author":[{"given":"Syed","family":"Bukhari","sequence":"first","affiliation":[{"name":"Department of Medicine, Temple University Hospital, Philadelphia, PA 19111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubair","family":"Bashir","sequence":"additional","affiliation":[{"name":"Department of Medicine, Alpert Medical School of Brown University, Providence, RI 02903, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular Mechanisms of Amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2967\/jnumed.120.245381","article-title":"Molecular Imaging of Cardiac Amyloidosis","volume":"61","author":"Masri","year":"2020","journal-title":"J. Nucl. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/03009734.2015.1122687","article-title":"(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis","volume":"121","author":"Pilebro","year":"2016","journal-title":"Ups. J. Med. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.jacc.2006.01.042","article-title":"Transthyretin V122I in African Americans with congestive heart failure","volume":"47","author":"Buxbaum","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Robles","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Narotsky","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijcard.2019.07.051","article-title":"Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy","volume":"300","author":"Maurizi","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bukhari, S., Khan, S.Z., Ghoweba, M., Khan, B., and Bashir, Z. (2024). Arrhythmias and Device Therapies in Cardiac Amyloidosis. J. Clin. Med., 13.","DOI":"10.20944\/preprints202401.1316.v1"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMc1917321","article-title":"Epidemiologic and Survival Trends in Amyloidosis, 1987\u20132019","volume":"382","author":"Ravichandran","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"ytab252","DOI":"10.1093\/ehjcr\/ytab252","article-title":"Cardiac amyloid presenting as cardiogenic shock: Case series","volume":"5","author":"Oye","year":"2021","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","article-title":"Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis","volume":"2","author":"Dorbala","year":"2014","journal-title":"JACC Heart Fail."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101912","DOI":"10.1016\/j.cpcardiol.2023.101912","article-title":"Bradyarrhythmias in Cardiac Amyloidosis and Role of Pacemaker","volume":"48","author":"Bukhari","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jjcc.2023.02.009","article-title":"Prevalence of ventricular arrhythmias and role of implantable cardioverter-defibrillator in cardiac amyloidosis","volume":"81","author":"Bukhari","year":"2023","journal-title":"J. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.120.052136","article-title":"Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy","volume":"143","author":"Bukhari","year":"2021","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ejhf.1742","article-title":"Carpal tunnel syndrome in cardiac amyloidosis: Implications for early diagnosis and prognostic role across the spectrum of aetiologies","volume":"22","author":"Milandri","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release","volume":"72","author":"Sperry","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2022.06.026","article-title":"Screening for Cardiac Amyloidosis 5 to 15 Years After Surgery for Bilateral Carpal Tunnel Syndrome","volume":"80","author":"Westin","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1111\/jgs.17976","article-title":"Analysis of lumbar spine stenosis specimens for identification of amyloid","volume":"70","author":"Maurer","year":"2022","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2017.9236","article-title":"Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis","volume":"318","author":"Geller","year":"2017","journal-title":"J. Am. Med. Assoc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/13506129.2017.1375908","article-title":"Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: Can we identify affected patients earlier?","volume":"24","author":"Rubin","year":"2017","journal-title":"Amyloid"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.26599\/1671-5411.2023.05.006","article-title":"Cardiac amyloidosis: State-of-the-art review","volume":"20","author":"Bukhari","year":"2023","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"A31","DOI":"10.1016\/j.echo.2022.06.006","article-title":"Practical Points for Echocardiography in Cardiac Amyloidosis","volume":"35","author":"Cuddy","year":"2022","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s10741-023-10332-3","article-title":"Advance of echocardiography in cardiac amyloidosis","volume":"28","author":"Liang","year":"2023","journal-title":"Heart Fail. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","article-title":"How to Image Cardiac Amyloidosis: A Practical Approach","volume":"13","author":"Dorbala","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1093\/eurheartj\/ehac543","article-title":"Restrictive cardiomyopathy: Definition and diagnosis","volume":"43","author":"Rapezzi","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41569-020-0334-7","article-title":"Diagnostic imaging of cardiac amyloidosis","volume":"17","author":"Baksi","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pcad.2023.07.003","article-title":"Insight into different phenotypic presentations of heart failure with preserved ejection fraction","volume":"79","author":"Bashir","year":"2023","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_32","first-page":"e000030","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e12967","DOI":"10.1111\/anec.12967","article-title":"Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis","volume":"27","author":"Ng","year":"2022","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jcmg.2018.06.016","article-title":"Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits","volume":"12","author":"Bravo","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","article-title":"Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis","volume":"129","author":"Quarta","year":"2014","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ehf2.13738","article-title":"Echocardiographic and clinical predictors of cardiac amyloidosis: Limitations of apical sparing","volume":"9","author":"Kyrouac","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/ejhf.2200","article-title":"Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans","volume":"23","author":"Minamisawa","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10815589241261279","DOI":"10.1177\/10815589241261279","article-title":"EXPRESS: Epidemiology, Diagnosis and Management of Cardiac Amyloidosis","volume":"13","author":"Bashir","year":"2024","journal-title":"J. Investig. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ehjci\/jeaa415","article-title":"Determinants of left atrial reservoir and pump strain and use of atrial strain for evaluation of left ventricular filling pressure","volume":"23","author":"Inoue","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ehjci\/jeac057","article-title":"Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cardfail.2022.08.008","article-title":"Atrial Fibrillation, Thromboembolic Risk, and Anticoagulation in Cardiac Amyloidosis: A Review","volume":"29","author":"Bukhari","year":"2023","journal-title":"J. Card. Fail."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jcmg.2023.01.015","article-title":"Prognostic Utility of Left Atrial Strain to Predict Thrombotic Events and Mortality in Amyloid Cardiomyopathy","volume":"16","author":"Akintoye","year":"2023","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"101571","DOI":"10.1016\/j.cpcardiol.2022.101571","article-title":"Epidemiology, Mechanisms, and Management of Atrial Fibrillation in Cardiac Amyloidosis","volume":"48","author":"Bukhari","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.echo.2019.03.005","article-title":"Role of Right Ventricular Strain Measured by Two-Dimensional Echocardiography in the Diagnosis of Cardiac Amyloidosis","volume":"32","author":"Sanabria","year":"2019","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e010249","DOI":"10.1161\/CIRCIMAGING.119.010249","article-title":"Efficient 1-Hour Technetium-99 m Pyrophosphate Imaging Protocol for the Diagnosis of Transthyretin Cardiac Amyloidosis","volume":"13","author":"Masri","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","article-title":"Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: Implications for utilizing nuclear medicine studies to subtype amyloidosis","volume":"25","author":"Stats","year":"2016","journal-title":"Cardiovasc. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis","volume":"13","author":"Musumeci","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular Magnetic Resonance in Cardiac Amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zhao, L., Tian, Z., and Fang, Q. (2016). Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: A systematic review and meta-analysis. BMC Cardiovasc. Disord., 16.","DOI":"10.1186\/s12872-016-0311-6"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4103\/ijri.IJRI_84_18","article-title":"Myocardial nulling pattern in cardiac amyloidosis on time of inversion scout magnetic resonance imaging sequence\u2014A new observation of temporal variability","volume":"28","author":"Mahalingam","year":"2018","journal-title":"Indian J. Radiol. Imaging"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and Extracellular Volume in Transthyretin Amyloidosis","volume":"12","author":"Kotecha","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: An equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s12350-021-02670-2","article-title":"Adding value to myocardial perfusion scintigraphy: A prediction tool to predict adverse cardiac outcomes and risk stratify","volume":"28","author":"Nieves","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Olausson, E., Wertz, J., Fridman, Y., Bering, P., Maanja, M., Niklasson, L., Wong, T.C., Fukui, M., Cavalcante, J.L., and Cater, G. (2023). Diffuse myocardial fibrosis associates with incident ventricular arrhythmia in implantable cardioverter defibrillator recipients. medRxiv.","DOI":"10.1101\/2023.02.15.23285925"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ehf2.12203","article-title":"Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis","volume":"5","author":"Takashio","year":"2018","journal-title":"ESC Heart Fail."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System","volume":"68","author":"Grogan","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/CIRCULATIONAHA.120.051460","article-title":"American College of Cardiology Cardiovascular Disease in Women Committee. Maternal Stroke: A Call for Action","volume":"143","author":"Elgendy","year":"2021","journal-title":"Circulation"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Bukhari, S., Yaghi, S., and Bashir, Z. (2023). Stroke in Young Adults. J. Clin. Med., 12.","DOI":"10.3390\/jcm12154999"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J. Clin. Oncol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/14\/4075\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:15:41Z","timestamp":1760109341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/14\/4075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":67,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["jcm13144075"],"URL":"https:\/\/doi.org\/10.3390\/jcm13144075","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]}}}